Modulation of costimulation to enhance tumor immunity.
Vesosky
Bridget
B
Department of Microbiology and Immunology, SUNY Upstate Medical University, 2204 Weiskotten Hall, 766 Irving Avenue, Syracuse, NY 13210, USA.
Hurwitz
Arthur A
AA
D015703:Antigens, CD / Q000276:immunology; D000943:Antigens, Differentiation; D000945:Antigens, Differentiation, T-Lymphocyte / Q000276:immunology; D000954:Antigens, Surface; D051017:Apoptosis Regulatory Proteins; D060887:B7 Antigens; D018122:B7-1 Antigen / Q000276:immunology; D051940:B7-2 Antigen; D018106:CD28 Antigens / Q000276:immunology; D019013:CD40 Antigens / Q000276:immunology; D060908:CTLA-4 Antigen; D002986:Clinical Trials as Topic; D006801:Humans; D060889:Inducible T-Cell Co-Stimulator Protein; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000276:immunology; D008565:Membrane Proteins; D009369:Neoplasms / Q000276:immunology*; D061026:Programmed Cell Death 1 Receptor; D011506:Proteins / Q000276:immunology; D011971:Receptors, Immunologic; D053262:Receptors, OX40; D018124:Receptors, Tumor Necrosis Factor; D013601:T-Lymphocytes / Q000276:immunology*; D014409:Tumor Necrosis Factor-alpha / Q000276:immunology
D015703:Antigens, CD; D000943:Antigens, Differentiation; D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface; D051017:Apoptosis Regulatory Proteins; D060887:B7 Antigens; D018122:B7-1 Antigen; D051940:B7-2 Antigen; C423237:CD276 protein, human; D018106:CD28 Antigens; D019013:CD40 Antigens; C497964:CD86 protein, human; D060908:CTLA-4 Antigen; C556706:CTLA4 protein, human; C556692:ICOS protein, human; D060889:Inducible T-Cell Co-Stimulator Protein; D008562:Membrane Glycoproteins; D008565:Membrane Proteins; C105992:PDCD1 protein, human; D061026:Programmed Cell Death 1 Receptor; D011506:Proteins; D011971:Receptors, Immunologic; D053262:Receptors, OX40; D018124:Receptors, Tumor Necrosis Factor; C505716:TNFRSF4 protein, human; D014409:Tumor Necrosis Factor-alpha